Treatment of Aβ42 alone showed a trend of increase in the basal level of NF-κB activity in BMMs at 0.5, 1, 5, and 10 μM ( Figure 2 A).
← all excerpts
Amyloid β Peptide Enhances RANKL-Induced Osteoclast Activation through NF-κB, ERK, and Calcium Oscillation Signaling.
1
—
—